6 May 2014 - Deborah Wilkes
Archived
Pfizer has increased its takeover proposal for AstraZeneca, but the UK-based company has rejected the cash and shares offer worth around £63.0 billion (US$106 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.